Global Dyslipidemia Drugs Market: Segment Snapshot and Table of Content (2015-2023)

Patent Expiries to Severely Constrain Growth of Global Dyslipidemia Drugs Market until 2023, TMR Says

The research report states the global dyslipidemia drugs market is expected to decline to US$6.88 bn by 2023 from US$17.85 bn in 2014. Between 2015 and 2023, the global market is expected to witness a declining CAGR of -10.3%.

Read Report Overview @ https://www.transparencymarketresearch.com/dyslipidemia-market.html

The Global Dyslipidemia Drugs Market is segmented on the basis of Drug Class and Geography.

Out of the various drug classes, the fibric acid and omega-3 fatty acid derivatives segment will exhibit the least decline, at a CAGR of -1.6% during the forecast period. Rising number of prescriptions for drugs such as Lovaza, Epanova, and Vascespa will help this segment gain slight momentum in the overall competitive landscape in the coming few years. By the end of 2023, the fibric acid and omega-3 fatty acid derivatives segment will reach a valuation of US$1,003.2 mn.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1535

Geographically, the drop in the Europe dyslipidemia market will be comparatively lower at a -9.9% CAGR between 2015 and 2023. The factors mitigating the losses of the dyslipidemia market across Europe will be supportive norms for the pharmaceutical manufacturing sector and higher consumer spending on branded formulations.

Summary of Table of Content

1 Introduction
2 Executive Summary
3 Market Overview
4 Dyslipidemia Drugs Market, by Drug Class
5 Dyslipidemia Drugs Market, by Geography
6 Recommendations
7 Company Profiles

Request to Browse Full Table of Content, figure and Tables @ https://www.transparencymarketresearch.com/report-toc/1535

ABOUT US:
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

CONTACT:
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-345

This release was published on openPR.